GMP

In recent decades, the medical toolbox has expanded dramatically. While traditional medicine relied on synthetic drugs (small molecules interacting with specific pathways) and later biologicals like antibodies, we have now entered the era of ...

On the 1st of December 2025, Aiko Ballardini, quality control specialist at the Innovation Center for Advanced Therapies (ICAT) of the University Medical Center Utrecht will present in our CTGCT Science Talks webinar series.

We were thrilled to host Dr. Andrea Rayat for our recent CTGCT Science Talks webinar. Dr. Rayat, an Associate Professor in bioseparations and downstream processing at University College London, delivered an insightful presentation titled, ...

A hands-on workshop on 4D-Nucleofector technology provided insights into gene transfer using Lonza’s Core- and X units. Participants learned about nucleofection, optimized protocols, and best practices for efficient gene delivery in cell-based research.

case study on the Braintree Manufacturing Innovation Centre (Braintree MIC), recently licensed by the MHRA. This state-of-the-art facility is revolutionizing the field of advanced therapy medicinal products (ATMPs) by providing cutting-edge infrastructure and expertise ...

Translational Medicine Ecosystem Ljubljana, Slovenia, Friday 18th October 2024, Location: Kemijski inštitut online transmission of event: webex teleconferencing link   8:30 Registration 9:00 Welcome Addresses Gregor Anderluh, National Institute of Chemistry Mojca Benčina, CTGCT ...

Our partner University College London (UCL) have produced a great short brochure (link) showing the strength and depth  of their pipeline of ATMPs. They use a managed portfolio approach in which they support ~100 ...

The CTGCT organised its first Panel Discussion on 29 May entitled: ATMP Regulation. The main takeaway from the very successful session was that the strong potential of the Slovenian ecosystem requires the will to ...